Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-602-5 | CAS number: 17625-03-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- Adopted on 28 July 2015
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Sodium hydrogen m-sulphonatobenzoate
- EC Number:
- 241-602-5
- EC Name:
- Sodium hydrogen m-sulphonatobenzoate
- Cas Number:
- 17625-03-5
- Molecular formula:
- C7H6O5S.Na
- IUPAC Name:
- sodium 3-sulfobenzoate
- Test material form:
- solid: particulate/powder
- Details on test material:
- White crystalline powder.
Constituent 1
- Specific details on test material used for the study:
- Identity Sodium 3-sulfobenzoate
Alternative names 3-Sulpho Benzoic AcidMono Sodium Salt
SBA (3-Sodiosulfobenzoic Acid)
Sodium hydrogen m-sulphonatobenzoate
Label name 3-Sodiosulfobenzoic Acid
Batch no. 170103
Retest date 14 February 2019
Storage conditions Room temperature
RTC number 15432
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Details on test system:
- The test system EPISKINTM is commercially available from SkinEthic Laboratories.
Characteristic of the test system
The SkinEthic reconstructed human tissue model EPISKINTM consists of an airlifted, living, multi-layered tissue construct, produced in polycarbonate inserts in serum-free and chemically defined medium, featuring normal ultra-structure and functionality equivalent to human tissue in vivo.
Normal human keratinocytes are used to reconstruct the epithelium. Multiple layers of viable epithelial cells (basal layer, stratum spinosum, stratum granulosum) should be present under a functional stratum corneum. Stratum corneum should be multilayered containing the essential lipid profile to produce a functional barrier with robustness to resist rapid penetration of cytotoxic marker chemicals.
Functional conditions
The barrier function should be demonstrated. The containment properties of the RhE model should prevent the passage of material around the stratum corneum to the viable tissue, which would lead to poor modelling of skin exposure. The RhE model supplier should ensure that each batch of the RhE model used meets defined production release criteria. A certificate will be supplied for each batch of the test system.
Preparation and storage of the test system
Immediately after arrival, the plate will be opened under a sterile airflow and the sterile filter paper removed. Each insert containing the epidermal tissue will be carefully taken out. Any remaining agarose that adheres to the outer sides of the insert will be rapidly removed by gentle blotting on the sterile filter paper. Inserts will be quickly placed in a 12-well plate (supplied) in which each well has previously been filled with 2 mL/well SkinEthic. Maintenance Medium (at room temperature) making sure that no air bubbles are formed underneath the inserts.
Culture dishes will be placed in the incubator at 37°C, 5% CO2 and saturated humidity. Testing can initiate after at least two hours of incubation. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- In the Main Assay, alive tissues were treated with the test item, positive and negative controls. The treatment scheme was the following:
Negative control (D-PBS) amount per well 20 µL (3 replicates)
Positive control (5% (w/v) SDS) amount per well 20 µL (3 replicates)
Test Item (sodium 3-sulfobenzoate) amount per well 20 mg (3 replicates). - Duration of treatment / exposure:
- Exposure period
An exposure time of 15±0.5 minutes was allowed in a ventilated cabinet at room temperature.
Washing
At the end of the exposure, each tissue was rinsed with approximately 25mL of sterile D-PBS, filling and empting the tissue insert. The excess liquid was carefully removed and the sample transferred in new wells pre-filled with 2mL/well of maintenance medium. - Duration of post-treatment incubation (if applicable):
- Post-exposure period
A 42 ± 1 hour recovery period was allowed by incubation at 37°C, 5% CO2 and saturated humidity. - Number of replicates:
- 3
Results and discussion
In vitro
Resultsopen allclose all
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- experiment 1 (A1)
- Value:
- 93.2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 110.4 % tissue viability
- Positive controls validity:
- valid
- Remarks:
- 3.1 % tissue viability
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- experiment 2 (A2)
- Value:
- 118
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 89.8 % tissue viability
- Positive controls validity:
- valid
- Remarks:
- 4.6 % tissue viability
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- experiment 3 (A3)
- Value:
- 96.2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 99.8 % tissue viability
- Positive controls validity:
- valid
- Remarks:
- 4.5 % tissue viability
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Mean
- Value:
- 102
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100 % tissue viability (mean)
- Positive controls validity:
- valid
- Remarks:
- 4 % tissue viability (mean)
Any other information on results incl. tables
Preliminary test
Before the Main Assay, a preliminary test was carried out to evaluate the compatibility of the test item with the test system. In a first step, the test item was assayed for the ability of reducing MTT per se. An opaque yellow colour was noted in the MTT solution at the end of the incubation period. This no relevant colour change indicated that the test item could not direct interact with MTT.
In a second step, the test item was assayed for the ability of colouring water per se. A colourless solution was observed, indicating that the test item has no potential interfering ability.
Based on the results obtained, no additional control was added in the Main Assay.
Main Assay
A Main Assay was performed. The mean Optical Density of Blank Controls was 0.038, lower than the maximum acceptable value (0.1). The negative control gave the expected baseline value (Optical Density values of the three replicates higher than 0.6) and variability (Standard Deviation of the % viability lower or equal to 18), in agreement with guideline indications. According to the method, the mean value is considered the baseline value of the experiment and thus represents 100% of cell viability.
Positive control results indicated an appropriate cell death with an acceptable relative cell viability (4% of the negative control value). Variability between replicates gave also the expected value (SD of % viability = 0.8). Based on the stated criteria, mean viability, expressed as percentage of the negative control, lower or equal to 40% and standard deviation of % viability equal or lower than 18, the study was accepted as valid.
The test item did not induce cell death in any replicate, the mean cell viability after the blank subtraction was 102%, when compared to the negative control. Acceptable intra-replicate variability was obtained (SD of % viability = 13.5 lower than 18).
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The blank, negative and positive controls gave acceptable results and the study was accepted as valid. The mean cell viability of the test item treated tissues, after the blank subtraction, was 102%. Based on the results obtained, the test item Sodium 3-sulfobenzoate is classified as non-irritant to the skin (UN GHS No Category).
- Executive summary:
The potential of the test item Sodium 3-sulfobenzoate to be irritant to the skin was investigated through an in vitro skin irritation study (according to OECD Guideline 439), using a commercial reconstructed human epidermis (RhE) model named EPISKIN™.
The blank, negative and positive controls gave acceptable results and the study was accepted as valid. The mean cell viability of the test item treated tissues, after the blank subtraction, was 102%. Based on the results obtained, the test item Sodium 3-sulfobenzoate is classified as non-irritant to the skin (UN GHS No Category).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.